Approximately 1 in 18 people in the U.S. has an arrhythmia – an abnormal heart rhythm. That’s 5-percent of the population. Studies have shown that one in four Americans over the age of 40 could develop an arrhythmia. There are several treatments and therapies to manage arrhythmia. One of the more exciting treatments is the use of robotic technology.
An arrhythmia is a problem with the rate, or the rhythm, of the heartbeat. The heart may beat too quickly, too slowly, or with an irregular rhythm. Symptoms of arrhythmia may include palpitations, fainting, light-headedness, chest pain, or shortness of breath. They can be relatively harmless or life-threatening.
Cardiac ablation is a minimally invasive procedure that is the leading treatment for arrhythmias. A physician places a catheter into a blood vessel and navigates it to the heart. There, the arrhythmia can be diagnosed and treated.
But ablations can be challenging. In traditional cardiac ablations, the physician manipulates a catheter by hand to treat the heart. Controlling this catheter from the opposite end isn’t easy. Not only is it difficult to manipulate the catheter with the rigidity of its guide wires, but this rigidity also presents an increased risk of adverse events during the procedure.
Robotic technology introduces enhanced levels of precision and safety. In a robotic cardiac ablation, a magnet in the catheter’s tip allows direct control of the catheter using external computer-controlled magnets on robotic arms. The magnets and robotic technology remove the need for rigid guide wires – making the catheter softer and more pliable. This provides greater stability and lowers the likelihood of causing injury.
Robotic technology is designed to address the inherent challenges and risks of manual cardiac ablation. Robotic Magnetic Navigation (RMN) technology transforms catheter navigation and allows procedures to be performed with millimeter precision.
Stereotaxis is a pioneer and global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform minimally invasive endovascular procedures. They push the boundaries of technology and healthcare by improving patient care with robotic precision and safety. Stereotaxis technology has been used to treat over 100,000 patients around the world.
In June of 2019, Stereotaxis introduced the Genesis RMN as the next-generation robotic platform and a significant advancement in robotic magnetic navigation technology. The Genesis RMN System enriches robotic navigation with increased efficiency and reduced size over previous technology as well as an enhanced lab experience. Genesis is a leap forward in Robotic Magnetic Navigation technology and represents the future of robotics in electrophysiology.
With Genesis, Stereotaxis launched their Imaging Model S as an integrated complete solution for robotic interventional operating rooms. The Imaging Model S is a single-plan full-power X-ray system designed specifically with the Genesis RMN system. Developed in collaboration with Omega Medical Imaging, Stereotaxis Imaging uses modern fluoroscopy technology to support high-quality imaging while minimizing radiation exposure to patients and staff.
The risks of radiation exposure are well documented. The interventional X-ray systems designed and built by Omega provide an automatic, hands-free solution to radiation reduction – delivering the benefit of consistent and repeatable radiation reduction to patients and staff beyond anything else in use today.
AI image-guided ROI systems are proven to be safer than non-AI systems and are quickly becoming the new standard of care for interventional imaging. The publications and science on the advantages of AI are clear and proven in a study that compares an Omega AI image-guided ROI system to a competitor’s non-ROI system.
Innovative technologies like those developed by Stereotaxis and Omega allow physicians and hospitals to provide the best care to their patients. From robotic magnetic navigation that provides precision and safety to AI image-guided interventional systems that reduce radiation exposure, Stereotaxis and Omega create new standards of care.